Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
PUT
Rockwell Medical
RMTI
$28.2M
| $846K | ﹤0.01% |
699
+472
| +208% | +$320K |
|
3477
MIND Technology
MIND
$46.2M
| $844K | ﹤0.01% |
5,626
+178
| +3% | +$30K |
|
3478
PUT
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $843K | ﹤0.01% |
34,000
+15,000
| +79% | +$366K |
|
|
ZOLT
3479
CALL
DELISTED
ZOLTEK COMPANIES INC
ZOLT
| $843K | ﹤0.01% |
52,700
+41,200
| +358% | +$587K |
|
|
MMT
3480
Aberdeen Multi-Market Income Fund
MMT
$243M
| $842K | ﹤0.01% |
140,310
+26,089
| +23% | +$169K |
|
3481
FirstCash
FCFS
$8.78B
| $841K | ﹤0.01% |
14,763
-5,152
| -26% | -$280K |
|
|
SNCR
3482
DELISTED
Synchronoss Technologies
SNCR
| $840K | ﹤0.01% |
2,457
-264
| -10% | -$80.4K |
|
|
OVTI
3483
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $840K | ﹤0.01% |
56,009
+19,011
| +51% | +$316K |
|
3484
CALL
Factset
FDS
$10.2B
| $839K | ﹤0.01% |
7,700
+1,700
| +28% | +$184K |
|
|
AFSI
3485
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $839K | ﹤0.01% |
43,014
+38,185
| +791% | +$710K |
|
3486
CALL
Boston Scientific
BSX
$71.5B
| $838K | ﹤0.01% |
76,200
-11,300
| -13% | -$122K |
|
3487
CALL
ProShares UltraShort Euro
EUO
$33.1M
| $838K | ﹤0.01% |
49,300
+19,700
| +67% | +$365K |
|
3488
PUT
Ryder
R
$10.1B
| $838K | ﹤0.01% |
14,200
-1,900
| -12% | -$114K |
|
3489
PUT
Waters Corp
WAT
$39.9B
| $838K | ﹤0.01% |
7,900
-41,900
| -84% | -$4.3M |
|
3490
CALL
Dover
DOV
$28.4B
| $837K | ﹤0.01% |
14,023
+4,774
| +52% | +$275K |
|
3491
Old National Bancorp
ONB
$10.2B
| $837K | ﹤0.01% |
59,818
-36,344
| -38% | -$513K |
|
|
UTEK
3492
CALL
DELISTED
Ultratech Inc.
UTEK
| $837K | ﹤0.01% |
27,900
+18,000
| +182% | +$551K |
|
3493
CALL
ProShares Ultra Dow30
DDM
$548M
| $836K | ﹤0.01% |
105,600
+54,000
| +105% | +$438K |
|
3494
iShares California Muni Bond ETF
CMF
$4.62B
| $835K | ﹤0.01% |
15,472
+346
| +2% | +$18.6K |
|
3495
Glacier Bancorp
GBCI
$6.35B
| $835K | ﹤0.01% |
34,790
-17,247
| -33% | -$414K |
|
3496
PUT
United Therapeutics
UTHR
$23.1B
| $835K | ﹤0.01% |
10,700
-40,800
| -79% | -$2.98M |
|
|
IRE
3497
DELISTED
GOVERNOR-BK OF IRELND ADS NEW
IRE
| $835K | ﹤0.01% |
75,937
+33,176
| +78% | +$348K |
|
3498
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.49B
| $834K | ﹤0.01% |
7,945
-9,338
| -54% | -$981K |
|
|
SUNE
3499
PUT
DELISTED
SUNEDISON, INC COM
SUNE
| $834K | ﹤0.01% |
119,200
+85,200
| +251% | +$706K |
|
|
JNY
3500
DELISTED
JONES GROUP INC COM STK (PA)
JNY
| $833K | ﹤0.01% |
55,518
-5,442
| -9% | -$85.4K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.